期刊名称：ACTA PHARMACEUTICA SINICA B ISSN： 2211-3835 出版频率： Bi-monthly 出版社： INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 100050   出版社网址： http://www.imm.ac.cn/cn/bookinfo.asp?rstid=57 期刊网址： https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b 影响因子： 11.614 主题范畴： PHARMACOLOGY & PHARMACY;    China Journals 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal 《药学学报》英文刊       《药学学报》英文刊（Acta Pharmaceutica Sinica B, APSB）是由中国药学会和中国医学科学院药物研究所共同主办，由《药学学报》编辑部与荷兰Elsevier B.V.出版公司合作出版的药学综合性英文期刊，是《药学学报》的系列期刊，创刊于2011年6月。其办刊宗旨是在世界药学领域的前沿和高端，搭建学术交流平台，引领和促进本学科的发展，向世界展示中国学者在药学领域研究的特色和成果，增强其国际影响力，推动我国药学事业的发展。期刊致力于发表药学科学和技术研究高端和前沿性的论文，快速报道药学科学基础研究和应用进展。报道范围覆盖化学药物、中药和天然药物、抗生素、蛋白质、多肽类药物、生物技术药物等的合成、分离鉴定、质量控制、药理、制剂、代谢等的原创性、创新性科研成果，栏目设综述与述评、研究论文、研究简报。 《药学学报》英文刊采用开放获取（OA）出版模式，全世界读者可以免费阅读和下载本刊发表的文章全文。期刊内容在世界上最大的出版平台ScienceDirect发布，论文内容传播速度快、范围广、影响大。采用国际通用的英文投审稿系统，1个月完成审稿，4-5个月上线出版。 《药学学报》英文刊目前不收取版面费和审稿费，稿酬从优；免费为所录用的非英语母语作者的文章进行语言润色修改，并根据文章质量及被引用情况，评选优秀论文，向优秀论文的作者颁发荣誉证书和奖金。 《药学学报》英文刊已被俄罗斯文摘和荷兰医学等数据库收录。2012年在中国科协优秀国际科技期刊奖的评选中荣获三等奖，并获创办英文科技期刊项目的支持。   Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association Instructions to Authors • Submission checklist BEFORE YOU BEGIN • Ethics in publishing • Studies in humans and animals • Declaration of interest • Submission declaration and verification • Use of inclusive language • Contributors • Changes to authorship • Clinical trial results • Copyright • Role of the funding source • Open access PREPARATION • Peer review • Article structure • Essential title page information • Abstract • Keywords • Artwork • Tables • References • Video • Supplementary material • Research data AFTER ACCEPTANCE • Online proof correction • Offprints AUTHOR INQUIRIES Editorial Board Editor-in-Chief J.D. Jiang Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaEmail J.D. Jiang Associate Editors-in-Chief Shi-Lin Chen Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China Xin-xin Ding University of Arizona, Tucson, USA De-an Guo Shanghai Inst. of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China Long-qin Hu Rutgers University, Piscataway, New Jersey, USA Rong-guang Shao Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Jian-Gong Shi Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Xiao-liang Wang Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Jian-ping Ye Louisiana State University, Baton Rouge, USA Qiang Zhang Sch. of Pharmaceutical Sciences, Peking University, Beijing, China Academic Consultants David W. Boykin Dept. of Chemistry, Georgia State University, Atlanta, Georgia, USA Yung-Chi Cheng Department of Pharmacology, Yale University, New Haven, Connecticut, USA Jian Ding Shanghai Institute of Materia Medica, Chinese Academy of Medical Sciences, Shanghai, China Zong-ru Guo Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Chang-xiao Liu Tianjin Institute of Pharmaceutical Research, Tianjin, China Pei-gen Xiao Inst. of Medicinal Plant Development, Chinese Academy of Medical Sciences, Beijing, China Bao-feng Yang Dept. of Pharmacology, Harbin Medical University, Harbin, Heilongjiang, China De-quan Yu Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Yong-su Zhen Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College Hong-hao Zhou Central South University, Changsha, China Tong-hui Zhou Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China